Clinical Trials Browser

Has results × Triple Negative Breast Neoplasms × Erlotinib Hydrochloride × Clear all

NCT00733408 2018-12-04

Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast Cancer

Phase 2 Completed

59 enrolled 14 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00834678 2018-04-17

Bendamustine and Erlotinib in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Breast Cancer

Phase 1/2 Completed

11 enrolled 16 charts

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms